Resources

Results 26 - 50 of 150

The HRH Action Framework is designed to assist governments and health managers to develop and implement strategies to achieve an effective and sustainable health workforce.

La Herramienta de Administración y Sustentabilidad Organizacional para Programas Nacionales de Control de la TB (MOST para la TB) es un proceso para mejorar la administración de un PNCT, cuyo resultado final es contribuir a lograr los tres objetivos principales de los PNCT.

By Newbrander, W., C. Peercy, M. Shepherd-Banigan, and P. Vergeer.International Journal of Health Planning and Management Epub 28 October 2011.

Purpose: To improve maternal and child health by empowering people to take better care of their health, strengthening communities and local governments' health management capacity, and promoting healthy lifestyles. Tool description:

The Compendium can be searched by the following categories: technical area, region, country, target population, and type of practice (best practice or promising practice). You can narrow your results further by using the keyword search.

This tool, an interactive training DVD, is appropriate for advocating and training on family planning and maternal, neonatal, and child health, targeting primary and secondary facility level providers and trainers, as well as for community health workers.

FinMAT helps managers assess their organizations’ financial management capacity, identify areas for improvement, make specific action plans to address shortcomings, and monitor for improvement The heart of FinMAT is an instrument for collecting and summarizing technical information about an organization’s financial management systems and practices.

HOSPICAL: A Tool for Allocating Hospital Costs can help improve a hospital’s performance and enhance its financial sustainability. Managers who use this practical tool will find it a tremendous aid in analyzing current costs and revenues, comparing efficiency, and forecasting what those figures would be if hospital services are expanded or modified.

In Namibia, Togo, and 10 other countries, MSH pioneered the Electronic Dispensing Tool, a cutting-edge information system that uses the patient as the focal point and captures critical information needed to make decisions about an individual’s drug regimen, as well as stock inventory and aggregate patient statistics. How it's used

The first management book written specifically for family planning program managers, this award-winning handbook has become a standard text in management training courses around the world.A practical guide for managers of health and family planning programs, this handbook provides practical information on:planningcoordinationstaffingsupervisiontrainingmanagement informationcontraceptive logisticsf

Managers everywhere need specific solutions to the critical challenges facing public health and development programs.

In a world of rising health care costs and increasing health care needs, access to tested approaches and techniques in the management of health care is more vital than ever. This compendium offers practical tools and techniques to address current challenges in public health management.

PurposeThe purpose of the Community Health Services Costing Tool is to help managers and planners estimate the costs of providing health services at the community level. It can be used for individual community services, packages of services, or for all community services.

TB is a major problem in many countries and consumes significant external and domestic resources.

Purpose The results and analysis will provide evidence-based data for implementing, scaling-up, and maintaining iCCM activities that will be invaluable for successful funding advocacy, for conducting feasibility/sustainability studies, for assessment of cost-effectiveness, and for planning financing strategies and mechanisms. Description

Purpose The Cost and Staffing Projection Tool is used to estimate the costs of achieving health worker staffing targets, comprising salaries and pre-service training costs. Description

Multi-Drug Resistant TB is a major problem in many countries. Cases can be difficult to find and hard and expensive to treat. This tool provides a simple way for managers to compare the cost-effectiveness of different diagnostic and treatment strategies (e.g. hospitalized versus ambulatory treatment systems). 

Multi-Drug Resistant (MDR) TB patients incur significant costs for seeking and undergoing treatment. It is important to understand these costs to develop appropriate levels of social protection to prevent people from deciding not to seek diagnosis or discontinuing treatment, or from suffering economic hardship as a result of treatment. 

The Human Resource Management (HRM) Rapid Assessment Tool offers a method for assessing an organization’s human resource management system and how well it functions. This tool helps users to develop strategies to improve the human resource management system and make it as effective as possible. It is designed to be used in public and private health organizations.

The Multidrug Resistant Tuberculosis (MDR-TB) Cost Effectiveness Analysis Tool is a simple, user-friendly, generic tool that is allows countries to compare the cost-effectiveness of different MDR-TB diagnoses and treatment methods. The tool builds on previous studies about MDR-TB control cost-effectiveness and WHO guidelines on TB control costs and cost-effectiveness.

Why is Gender Responsiveness in Health Governance so important? Gender-responsiveness in governance has the potential to enhance positive health outcomes not only for women but also for the entire community. Women play three important roles in a health system: 1) as decision makers; 2) as health workers and health care providers; and 3) as users of services.

This resource was designed to help Kenyan civil society organizations (CSOs) working in the health sector to become more effective, efficient, results oriented, and sustainable.

All medicines carry some risk of adverse events; although certain risks are identified when medicines are tested during clinical trials, others aren’t recognized until after the medicine is on the market and has been used in “real world” settings.

Pages